Focused ultrasound thalamotomy, a form of non-invasive brain surgery that uses sound waves, has been shown to improve the motor function and overall quality of life in patients with drug-resistant Parkinson’s disease, according to new research at the University of Virginia (UVA) School of Medicine.

In previous research, the ultrasound technique was shown to improve tremors, a hallmark symptom of Parkinson’s disease. The new study adds to these findings, showing that the procedure is also safe in regard to mood, behavior and cognitive ability — areas largely neglected in previous research — and that the approach tends to lead to enhanced emotional well-being and greater quality of life.

“In our initial study that looked at the outcomes of focused ultrasound surgery in Parkinson’s disease, we primarily described post-operative improvements in motor symptoms, specifically tremor,” said Scott Sperling, Psy.D., a clinical neuropsychologist at UVA.

“In this study, we extended these initial results and showed that focused ultrasound thalamotomy is not only safe from a cognitive and mood perspective, but that patients who underwent surgery realized significant and sustained benefits in terms of functional disability and overall quality of life.”

Focused ultrasound has been approved by the federal Food and Drug Administration for the treatment of essential tremor, the most common movement disorder. That approval came after a pioneering international study led by UVA neurosurgeon Jeff Elias, M.D.

Elias and his colleagues have since demonstrated the procedure’s potential in reducing tremor in people with drug-resistant Parkinson’s disease. The technique uses focused sound waves to interrupt the faulty brain circuits responsible for the uncontrollable shaking associated with the disease.

The new study involved 27 adults, all with severe Parkinson’s tremor that had not responded to previous treatment. The study participants were initially divided into two groups: 20 received the procedure, while seven received a fake procedure, to serve as a control group. (Those in the control group were later offered the opportunity to receive the real procedure, and all but one did.)

After receiving the procedure, study participants reported improved quality of life at both three months and 12 months.

“After surgery, patients experienced significant improvements in multiple aspects of quality of life, including their ability to perform simple daily tasks, emotional well-being and the sense of stigma they experienced due to their tremor,” Sperling said.

“Our results suggest that post-operative improvements in tremor lead to very meaningful improvements in day-to-day functioning and, subsequently, to better overall quality of life.”

The study was unique in that it gave an in-depth examination of the psychological and cognitive effects of the procedure, areas that have received relatively little attention in previous research.

The researchers found that mood and cognition, and the ability to go about daily life, ultimately had more effect on participants’ assessment of their overall quality of life than did their tremor severity or the amount of tremor improvement seen after the procedure.

“A person’s perception of their quality of life is shaped in many different ways,” Sperling said. “Mood and behavioral symptoms, such as depression, anxiety and apathy, often have a greater impact on quality of life than the measurable severity of one’s tremor.”

The only cognitive declines seen in participants were in how quickly they were able to name colors and think of and speak words. The cause of this was unclear, though the researchers suggest this could be a result of the natural progression of Parkinson’s. (Focused ultrasound is being tested to address the tremor associated with the disease, not its other symptoms.)

The researchers say the study was limited by its small size and the fact that participants’ medication dosing varied, among other factors.

Source: University of Virginia Health System